Targeting cholesterol metabolism in tumor and its immune microenvironment: opportunities and challenges

Ziyi Wang1, Xinyan Li2, Xiangyu Sun3

  • 1Department of Surgical Oncology and General Surgery, First Hospital of China Medical University, Shenyang, Liaoning Province 110001, China; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China; Department of Thoracic Surgery, First Hospital of China Medical University, Shenyang, Liaoning Province 110001, China.

Insights

Cholesterol metabolism reprogramming fuels tumor growth and impacts the tumor immune microenvironment. Targeting cholesterol metabolism offers new strategies to enhance anti-tumor immunity and cancer therapies.

Area of Science:

  • Oncology
  • Immunology
  • Metabolic pathways

Background:

  • Cholesterol metabolism is essential for cellular functions and membrane integrity.
  • Aberrant cholesterol metabolism is a key characteristic of many cancers.
  • Tumor microenvironment cues significantly alter cholesterol metabolism, promoting cancer progression.

Purpose of the Study:

  • To review the reprogramming of cholesterol metabolism in tumors.
  • To explore the intricate relationship between cholesterol metabolism and anti-tumor immunity.
  • To identify potential therapeutic strategies targeting cholesterol metabolism in cancer.

Main Methods:

  • Literature review of clinical studies and mechanistic investigations.
  • Analysis of current insights into cholesterol metabolism pathways in cancer.
  • Exploration of the interplay between cholesterol metabolism and immune components.

Main Results:

  • Dysregulated cholesterol metabolism drives tumorigenesis and tumor development.
  • Metabolic vulnerabilities in cholesterol pathways present therapeutic opportunities.
  • Modulating cholesterol metabolism can reshape the tumor immune landscape.

Conclusions:

  • Understanding cholesterol metabolism's role in tumors and the immune microenvironment is crucial.
  • Targeting cholesterol metabolism may enhance current immunotherapies.
  • Novel clinical strategies can be developed by targeting cholesterol metabolism in cancer.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
686
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K